Prof Nyirenda is currently Deputy Director at the MRC/UVRI & LSHTM Uganda Research Unit, Professor of Medicine and Global Non-Communicable Diseases, and Head of the Unit’s Non-Communicable Disease Research theme.His prominent career has ranged from molecular medicine to clinical and public health research, including investigations into non-communicable diseases, particularly around diabetes, obesity, and hypertension. He also has a strong interest in capacity building across Africa.
Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, research finds medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The Prepvacc HIV prevention study of experimental vaccine regimens and a new form of oral pre-exposure prophylaxis (PrEP) running in East and Southern Africa among 1,500 volunteer participants.
The Prepvacc HIV prevention study of experimental vaccine regimens and a new form of oral pre-exposure prophylaxis (PrEP) running in East and Southern Africa among 1,500 volunteer participants.